ℹ️
🇬🇧
Search
Search for people relevant for ""
Class
Person
Publication
Programmes
MUDr. Petra Kovaříková Ph.D.
Academic staff at First Faculty of Medicine
20 publications
Publications
publication
Ibrutinib in mantle cell lymphoma: a real-world retrospective multi-center analysis of 77 patients treated in the Czech Republic
2023 |
First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Third Faculty of Medicine
publication
Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas
2022 |
First Faculty of Medicine, Second Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Physical Education and Sport
publication
Quantitative In Vivo Monitoring of Hypoxia and Vascularization of Patient-Derived Murine Xenografts of Mantle Cell Lymphoma Using Photoacoustic and Ultrasound Imaging
2021 |
First Faculty of Medicine, Faculty of Medicine in Pilsen
publication
Cytarabine nanotherapeutics with increased stability and enhanced lymphoma uptake for tailored highly effective therapy of mantle cell lymphoma
2021 |
First Faculty of Medicine
publication
CD31/PECAM-1 impacts engraftment, growth and spread of mantle cell lymphoma cells and positively correlates with extramedullary involvement
2021 |
First Faculty of Medicine
publication
Dimethyl fumarate induces ferroptosis and impairs NF-kappa B/STAT3 signaling in DLBCL
2021 |
First Faculty of Medicine
publication
Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma
2020 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Overcoming resistance to rituximab in relapsed non-Hodgkin lymphomas by antibody-polymer drug conjugates actively targeted by anti-CD38 daratumumab
2020 |
First Faculty of Medicine
publication
Cotargeting of BCL2 with venetoclax and MCL1 with S63845 is synthetically lethal in vivo in relapsed mantle cell lymphoma
2019 |
First Faculty of Medicine, Second Faculty of Medicine
publication
Hematopoiesis in patients with mature B-cell malignancies is deregulated even in patients with undetectable bone marrow involvement
2017 |
First Faculty of Medicine
Load more publications (10)
Loading network view...